Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin dosing for VTE prophylaxis after total joint arthroplasty
NCT04295486Phase 2Recruiting
- Sponsor
- University of Miami
- Start
- Mar 2021
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in venous thromboembolism (VTE), sponsored by University of Miami. Started Mar 2021; status: recruiting.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04295486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04295486.